Browse > Article
http://dx.doi.org/10.4062/biomolther.2015.030

Neuroprotective and Antioxidant Effects of Novel Benzofuran-2-Carboxamide Derivatives  

Cho, Jungsook (College of Pharmacy, Dongguk University-Seoul)
Park, Chowee (College of Pharmacy, Dongguk University-Seoul)
Lee, Youngmun (College of Pharmacy, Dongguk University-Seoul)
Kim, Sunyoung (College of Pharmacy, Dongguk University-Seoul)
Bose, Shambhunath (College of Pharmacy, Dongguk University-Seoul)
Choi, Minho (Collegy of Pharmacy, Chungbuk National University)
Kumar, Arepalli Sateesh (Collegy of Pharmacy, Chungbuk National University)
Jung, Jae-Kyung (Collegy of Pharmacy, Chungbuk National University)
Lee, Heesoon (Collegy of Pharmacy, Chungbuk National University)
Publication Information
Biomolecules & Therapeutics / v.23, no.3, 2015 , pp. 275-282 More about this Journal
Abstract
In the present study, we synthesized a series of novel 7-methoxy-N-(substituted phenyl)benzofuran-2-carboxamide derivatives in moderate to good yields and evaluated their neuroprotective and antioxidant activities using primary cultured rat cortical neuronal cells and in vitro cell-free bioassays. Based on our primary screening data with eighteen synthesized derivatives, nine compounds (1a, 1c, 1f, 1i, 1j, 1l, 1p, 1q and 1r) exhibiting considerable protection against the NMDA-induced excitotoxic neuronal cell damage at the concentration of $100{\mu}M$ were selected for further evaluation. Among the selected derivatives, compound 1f (with $-CH_3$ substitution at R2 position) exhibited the most potent and efficacious neuroprotective action against the NMDA-induced excitotoxicity. Its neuroprotective effect was almost comparable to that of memantine, a well-known NMDA antagonist, at $30{\mu}M$ concentration. In addition to 1f, compound 1j (with -OH substitution at R3 position) also showed marked anti-excitotoxic effects at both 100 and $300{\mu}M$ concentrations. These findings suggest that $-CH_3$ substitution at R2 position and, to a lesser degree, -OH substitution at R3 position may be important for exhibiting neuroprotective action against excitotoxic damage. Compound 1j was also found to scavenge 1,1-diphenyl-2-picrylhydrazyl radicals and inhibit in vitro lipid peroxidation in rat brain homogenate in moderate and appreciable degrees. Taken together, our structure-activity relationship studies suggest that the compound with $-CH_3$ substitution at R2 and -OH substitution at R3 positions of the benzofuran moiety might serve as the lead exhibiting potent anti-excitotoxic, ROS scavenging, and antioxidant activities. Further synthesis and evaluation will be necessary to confirm this possibility.
Keywords
Neuroprotection; Excitotoxicity; Reactive oxygen species; Antioxidant activity; Benzofuran-2-carboxamide derivatives;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cho, J., Joo, N. E., Kong, J. Y., Jeong, D. Y., Lee, K. D. and Kang, B. S. (2000) Inhibition of excitotoxic neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neurons. J. Ethnopharmacol. 73, 31-37.   DOI
2 Cho, J., Kong, J. Y., Jeong, D. Y., Lee, K. D., Lee, D. U. and Kang, B. S. (2001) NMDA recepter-mediated neuroprotection by essential oils from the rhizomes of Acorus gramineus. Life Sci. 68, 1567-1573.   DOI
3 Cho, J. and Lee, H. K. (2004) Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. Eur. J. Pharmacol. 485, 105-110.   DOI
4 Cho, J., Kim, H. M., Ryu, J. H., Jeong, Y. S., Lee, Y. S. and Jin, C. (2005) Neuroprotective and antioxidant effects of the ethyl acetate fraction prepared from Tussilago farfara L. Biol. Pharm. Bull. 28, 455-460.   DOI
5 Choi, D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.   DOI
6 Chong, C. M., Shen, M., Zhou, Z. Y., Pan, P., Hoi, P. M., Li, S., Liang, W., Ai, N., Zhang, L. Q., Li, C. W., Yu, H., Hou, T. and Lee, S. M. (2014) Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against $MPP^+$-induced oxidative stress and cell death in SH-SY5Y cells. Free Radic. Biol. Med. 74, 283-293.   DOI
7 Coyle, J. T. and Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.   DOI
8 Dawood, K. M. (2013) Benzofuran derivatives: a patent review. Expert Opin.Ther. Pat. 23, 1133-1156.   DOI
9 Gaszner, P. and Miklya, I. (2006) Major depression and the synthetic enhancer substances, (-)-deprenyl and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 5-14.   DOI
10 Girouard, H., Wang, G., Gallo, E. F., Anrather, J., Zhou, P., Pickel, V. M. and Iadecola, C. (2009) NMDA receptor activation increases free radical production through nitric oxide and NOX2. J. Neurosci. 29, 2545-2552.   DOI
11 Howlett, D. R., Perry, A. E., Godfrey, F., Swatton, J. E., Jennings, K. H., Spitzfaden, C., Wadsworth, H., Wood, S. J. and Markwell, R. E. (1999) Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem. J. 340, 283-289.   DOI
12 Grisar, J. M., Bolkenius, F. N., Petty, M. A. and Verne, J. (1995) 2,3-Dihydro-1-benzofuran-5-ols as analogues of alpha-tocopherol that inhibit in vitro and ex vivo lipid autoxidation and protect mice against central nervous system trauma. J. Med. Chem. 38, 453-458.   DOI
13 Hall, E. D. (1993) Role of oxygen radicals in central nervous system trauma. In oxygen free radicals in tissue damage. (M. Tarr and F. Samson, Eds.), pp. 153-173. Birkhauser, Boston.
14 Han, Z., Yang, J. L., Jiang, S. X., Hou, S. T. and Zheng, R. Y. (2013) Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotection. PLoS One 8, e64894.   DOI
15 Kim, A. H., Kerchner, G. A., and Choi, D. W. (2002). Blocking excitotoxicity. In handbook of experimental pharmacology. (F.W. Marcoux and D.W. Choi, Eds.), pp. 3-36. Springer, New York.
16 Kim, S., Lee, Y. and Cho, J. (2014) Korean red ginseng extract exhibits neuroprotective effects through inhibition of apoptotic cell death. Biol. Pharm. Bull. 37, 938-946.   DOI
17 Lipton, S. A. and Rosenberg. P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622.   DOI
18 Manev, H. Favaron, M. Guidotti, A. and Costa, E. (1989) Delayed increase of $Ca^{2+}$ influx elicited by glutamate: role in neuronal death. Mol. Pharmacol. 36, 106-112.
19 Nicholls, D. G. (2004) Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr. Mol. Med. 4, 149-177.   DOI
20 Moosmann, B. and Behl, C. (2002) Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Investig. Drugs 11, 1407-1435   DOI
21 Rajan, P., Vedernikova, I., Cos, P., Berghe, D. V., Augustyns, K. and Haemers, A. (2001) Synthesis and evaluation of caffeic acid amides as antioxidants. Bioorg. Med. Chem. Lett. 11, 215-217.   DOI
22 Rindhe, S. S., Rode, M. A. and Karale, B. K. (2010) New benzofuran derivatives as an antioxidant agent. Indian J. Pharm. Sci. 72, 231-235.   DOI
23 Rizzo, S., Riviere, C., Piazzi, L., Bisi, A., Gobbi, S., Bartolini, M., Andrisano, V., Morroni, F., Tarozzi, A., Monti, J. P. and Rampa, A. (2008) Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity. J. Med. Chem. 51, 2883-2886.   DOI
24 Uttara, B., Singh, A. V., Zamboni, P. and Mahajan, R. T. (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7, 65-74.   DOI
25 Varvaresou, A., Iakovou, K., Filippatos, E., Souli, C., Calogeropoulou, T., Ioannidou, I., Kourounakis, A. P., Pannecouque, C., Witvrouw, M., Padalko, E., Neyts, J., De Clercq, E. and Tsotinis, A. (2001) Synthesis, antiretroviral and antioxidant evaluation of a series of new benzo[b]furan derivatives. Arzneimittelforschung 51, 156-162.